Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 1464-1472, April 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, D.
Right arrow Articles by Cavenee, W. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, D.
Right arrow Articles by Cavenee, W. K.
[Cancer Research 59, 1464-1472, April 1, 1999]
© 1999 American Association for Cancer Research


Biochemistry

Induction of Vascular Endothelial Growth Factor Expression in Endothelial Cells by Platelet-derived Growth Factor through the Activation of Phosphatidylinositol 3-Kinase

Degui Wang1,, 2, H-J. Su Huang, Andrius Kazlauskas and Webster K. Cavenee

Ludwig Institute for Cancer Research [D. W., H-J. S. H., W. K. C.], Department of Medicine [H-J. S. H., W. K. C.], Center for Molecular Genetics [W. K. C.], and Cancer Center [W. K. C.], University of California-San Diego, California 92093-0660, and Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts 02114 [A. K.]

Increased numbers of platelet-derived growth factor ß receptors (ßPDGFRs) on neovascular endothelial cells is a common occurrence in several pathological conditions including wound healing, inflammation, and glioma tumorigenesis. Here we sought to test the biological significance of this by determining whether expression of wild-type ßPDGFR by normal aortic endothelial cells affected the expression of the vascular endothelial growth factor (VEGF), a critical angiogenesis regulator and mitogen for such cells. The results showed that PDGF could increase transcription and secretion of VEGF by ßPDGFR-expressing endothelial cells. Moreover, we further demonstrated a requirement for the activation of phosphatidylinositol 3-kinase (PI3K) in this response by using chemical inhibitors of PI3K, mutant PDGFR, and dominant-negative PI3K. These studies suggest a novel mechanism by which PDGF induces VEGF expression in endothelial cells, define VEGF as a downstream target for PI3K, and invoke a role for PI3K in angiogenesis.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. J. Tomanek, H. K. Hansen, and L. P. Christensen
Temporally Expressed PDGF and FGF-2 Regulate Embryonic Coronary Artery Formation and Growth
Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1237 - 1243.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
S. de Bouard, P. Herlin, J. G. Christensen, E. Lemoisson, P. Gauduchon, E. Raymond, and J.-S. Guillamo
Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma
Neuro-oncol, October 1, 2007; 9(4): 412 - 423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Cho, T. Ishiwata, E. Uchida, N. Nakazawa, M. Korc, Z. Naito, and T. Tajiri
Enhanced Expression of Keratinocyte Growth Factor and Its Receptor Correlates with Venous Invasion in Pancreatic Cancer
Am. J. Pathol., June 1, 2007; 170(6): 1964 - 1974.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
I. F. Pollack, R. I. Jakacki, S. M. Blaney, M. L. Hancock, M. W. Kieran, P. Phillips, L. E. Kun, H. Friedman, R. Packer, A. Banerjee, et al.
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: A Pediatric Brain Tumor Consortium report
Neuro-oncol, April 1, 2007; 9(2): 145 - 160.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Ponten, E. Bergsten Folestad, K. Pietras, and U. Eriksson
Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice
Circ. Res., November 11, 2005; 97(10): 1036 - 1045.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
E. B. Dickerson, R. Thomas, S. P. Fosmire, A. R. Lamerato-Kozicki, S. R. Bianco, J. W. Wojcieszyn, M. Breen, S. C. Helfand, and J. F. Modiano
Mutations of Phosphatase and Tensin Homolog Deleted from Chromosome 10 in Canine Hemangiosarcoma
Vet. Pathol., September 1, 2005; 42(5): 618 - 632.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Xu, R. Tong, D. M. Cochran, and R. K. Jain
Blocking Platelet-Derived Growth Factor-D/Platelet-Derived Growth Factor Receptor {beta} Signaling Inhibits Human Renal Cell Carcinoma Progression in an Orthotopic Mouse Model
Cancer Res., July 1, 2005; 65(13): 5711 - 5719.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Ouchi, R. Shibata, and K. Walsh
AMP-Activated Protein Kinase Signaling Stimulates VEGF Expression and Angiogenesis in Skeletal Muscle
Circ. Res., April 29, 2005; 96(8): 838 - 846.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Basciani, M. Brama, S. Mariani, G. De Luca, M. Arizzi, L. Vesci, C. Pisano, S. Dolci, G. Spera, and L. Gnessi
Imatinib Mesylate Inhibits Leydig Cell Tumor Growth: Evidence for In vitro and In vivo Activity
Cancer Res., March 1, 2005; 65(5): 1897 - 1903.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. G. Roberts, P. M. Whalen, E. Soderstrom, G. Moraski, J. P. Lyssikatos, H.-F. Wang, B. Cooper, D. A. Baker, D. Savage, D. Dalvie, et al.
Antiangiogenic and Antitumor Activity of a Selective PDGFR Tyrosine Kinase Inhibitor, CP-673,451
Cancer Res., February 1, 2005; 65(3): 957 - 966.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Deng, S. Szabo, T. Khomenko, M. R. Jadus, and M. Yoshida
Gene Therapy with Adenoviral Plasmids or Naked DNA of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor Accelerates Healing of Duodenal Ulcer in Rats
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 982 - 988.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Y. Wu, Q. Zhang, D. K. Ann, A. Akhondzadeh, H. S. Duong, D. V. Messadi, and A. D. Le
Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts
Am J Physiol Cell Physiol, April 1, 2004; 286(4): C905 - C912.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Saucier, H. Khoury, K.-M. V. Lai, P. Peschard, D. Dankort, M. A. Naujokas, J. Holash, G. D. Yancopoulos, W. J. Muller, T. Pawson, et al.
The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis
PNAS, February 24, 2004; 101(8): 2345 - 2350.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Boguslawski, P. W. McGlynn, K. A. Harvey, and A. T. Kovala
SU1498, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Causes Accumulation of Phosphorylated ERK Kinases and Inhibits Their Activity in Vivo and in Vitro
J. Biol. Chem., February 13, 2004; 279(7): 5716 - 5724.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
D. J. Brat and T. B. Mapstone
Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor Progression
Ann Intern Med, April 15, 2003; 138(8): 659 - 668.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Guo, B. Hu, W. Gu, L. Xu, D. Wang, H.-J. S. Huang, W. K. Cavenee, and S.-Y. Cheng
Platelet-Derived Growth Factor-B Enhances Glioma Angiogenesis by Stimulating Vascular Endothelial Growth Factor Expression in Tumor Endothelia and by Promoting Pericyte Recruitment
Am. J. Pathol., April 1, 2003; 162(4): 1083 - 1093.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Kiriakidis, E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann, and E. Paleolog
VEGF expression in human macrophages is NF-{kappa}B-dependent: studies using adenoviruses expressing the endogenous NF-{kappa}B inhibitor I{kappa}B{alpha} and a kinase-defective form of the I{kappa}B kinase 2
J. Cell Sci., February 15, 2003; 116(4): 665 - 674.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Pore, S. Liu, D. A. Haas-Kogan, D. M. O'Rourke, and A. Maity
PTEN Mutation and Epidermal Growth Factor Receptor Activation Regulate Vascular Endothelial Growth Factor (VEGF) mRNA Expression in Human Glioblastoma Cells by Transactivating the Proximal VEGF Promoter
Cancer Res., January 1, 2003; 63(1): 236 - 241.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
S. A. Woods, C. J. McGlade, and A. Guha
Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells
Neuro-oncol, October 1, 2002; 4(4): 242 - 252.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, G. L. Semenza, and E. Van Obberghen
Insulin Stimulates Hypoxia-inducible Factor 1 through a Phosphatidylinositol 3-Kinase/Target of Rapamycin-dependent Signaling Pathway
J. Biol. Chem., July 26, 2002; 277(31): 27975 - 27981.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
C. B. Knobbe, A. Merlo, and G. Reifenberger
Pten signaling in gliomas
Neuro-oncol, July 1, 2002; 4(3): 196 - 211.
[Abstract] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
L. J. Metheny-Barlow, B. Flynn, H. E. van Gijssel, A. Marrogi, and B. I. Gerwin
Paradoxical Effects of Platelet-Derived Growth Factor-A Overexpression in Malignant Mesothelioma . Antiproliferative Effects In Vitro and Tumorigenic Stimulation In Vivo
Am. J. Respir. Cell Mol. Biol., June 1, 2001; 24(6): 694 - 702.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Y. Chen, N. M. Mazure, J. A. Cooper, and A. J. Giaccia
Hypoxia Activates a Platelet-derived Growth Factor Receptor/Phosphatidylinositol 3-Kinase/Akt Pathway That Results in Glycogen Synthase Kinase-3 Inactivation
Cancer Res., March 1, 2001; 61(6): 2429 - 2433.
[Abstract] [Full Text]


Home page
BloodHome page
B. D. Smolich, H. A. Yuen, K. A. West, F. J. Giles, M. Albitar, and J. M. Cherrington
The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts
Blood, March 1, 2001; 97(5): 1413 - 1421.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Xiong, R. Grijalva, L. Zhang, N. T. Nguyen, P. W. Pisters, R. E. Pollock, and D. Yu
Up-Regulation of Vascular Endothelial Growth Factor in Breast Cancer Cells by the Heregulin-{beta}1-activated p38 Signaling Pathway Enhances Endothelial Cell Migration
Cancer Res., February 1, 2001; 61(4): 1727 - 1732.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
A. Maity, N. Pore, J. Lee, D. Solomon, and D. M. O’Rourke
Epidermal Growth Factor Receptor Transcriptionally Up-Regulates Vascular Endothelial Growth Factor Expression in Human Glioblastoma Cells via a Pathway Involving Phosphatidylinositol 3'-Kinase and Distinct from That Induced by Hypoxia
Cancer Res., October 1, 2000; 60(20): 5879 - 5886.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
W. Zundel, C. Schindler, D. Haas-Kogan, A. Koong, F. Kaper, E. Chen, A. R. Gottschalk, H. E. Ryan, R. S. Johnson, A. B. Jefferson, et al.
Loss of PTEN facilitates HIF-1-mediated gene expression
Genes & Dev., February 15, 2000; 14(4): 391 - 396.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. Bagheri-Yarmand, R. K. Vadlamudi, R.-A. Wang, J. Mendelsohn, and R. Kumar
Vascular Endothelial Growth Factor Up-regulation via p21-activated Kinase-1 Signaling Regulates Heregulin-beta 1-mediated Angiogenesis
J. Biol. Chem., December 8, 2000; 275(50): 39451 - 39457.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B.-H. Jiang, J. Z. Zheng, M. Aoki, and P. K. Vogt
Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells
PNAS, February 15, 2000; 97(4): 1749 - 1753.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.